|
|
The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.
When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.
For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.
Approximately 25% of all reported medication errors result from some kind of name confusion.
Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.